Evidence map›Paper›PMID 41968009›Full record

ReviewTrends in neurosciences2026

Serotonergic and glutamatergic mechanisms converge in ketamine's rapid responses.

Manoela V Fogaça

Abstract readReview
In one paragraph

Review in Trends in neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Manoela V FogaçaDepartment of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA. Electronic address: manoela_fogaca@urmc.rochester.edu.

Funding

Cortical GABAergic mechanisms underlying rapid and sustained antidepressant responsesR00MH126098 · NIMH · UNIVERSITY OF ROCHESTER · PI FOGACA, MANOELA · 2023 to 2025
$730k
NIMH NIH HHS R00 MH126098
6 · The paper itself

Abstract

Ketamine's rapid antidepressant actions are commonly attributed to glutamatergic mechanisms. In a recent study, Luo and colleagues have shown that ketamine inhibits the serotonin transporter and that prefrontal serotonergic signaling synergizes with NMDA receptor blockade to recruit vasoactive intestinal peptide interneurons in mice, driving fast behavioral responses. These findings suggest convergent serotonergic and glutamatergic pathways underlying ketamine's antidepressant effects.

Indexed as

Antidepressive AgentsGlutamic AcidKetamineSerotoninAnimalsHumansReceptors, N-Methyl-D-AspartateSerotonin Plasma Membrane Transport ProteinsAntidepressive AgentsGlutamic AcidKetamineReceptors, N-Methyl-D-AspartateSerotoninSerotonin Plasma Membrane Transport ProteinsdepressionNMDA receptorsprefrontal cortexrapid-acting antidepressantsserotonin transporterVIP interneurons

Identifiers

PMID41968009
PMCPMC13078723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.